Evan Norton's most recent trade in NeuroPace Inc was a trade of 3,454,422 Series B Preferred Stock done . Disclosure was reported to the exchange on April 26, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NeuroPace Inc | Evan Norton | Director | 26 Apr 2021 | 3,454,422 | 0 | - | - | Series B Preferred Stock | ||
| NeuroPace Inc | Evan Norton | Director | 26 Apr 2021 | 3,454,422 | 4,042,657 | - | 0 | Common Stock | ||
| NeuroPace Inc | Evan Norton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2021 | 21,698 | 21,698 | - | - | Stock Option (Right to Buy) |